roughly $80 billion biopharmaceutical companyThe wide array of offerings helps fuel consistent payouts to shareholders. Current distributions are 73 cents per quarter, up 70% from 43 cents a share back at the beginning of 2016 and proof that this is a pharmaceutical stock committed to sharing its success with investors.